These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22919658)

  • 21. The multifarious, multireplicon Burkholderia cepacia complex.
    Mahenthiralingam E; Urban TA; Goldberg JB
    Nat Rev Microbiol; 2005 Feb; 3(2):144-56. PubMed ID: 15643431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells.
    Saldías MS; Valvano MA
    Microbiology (Reading); 2009 Sep; 155(Pt 9):2809-2817. PubMed ID: 19542002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?
    Kalferstova L; Kolar M; Fila L; Vavrova J; Drevinek P
    J Clin Microbiol; 2015 May; 53(5):1515-22. PubMed ID: 25694518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis.
    McKeon SA; Nguyen DT; Viteri DF; Zlosnik JE; Sokol PA
    J Infect Dis; 2011 Feb; 203(3):383-92. PubMed ID: 21208930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful Lung Re-transplant in a Patient with Cepacia Syndrome due to Burkholderia ambifaria.
    Goodlet KJ; Nailor MD; Omar A; Huang JL; LiPuma JJ; Walia R; Tokman S
    J Cyst Fibros; 2019 Jan; 18(1):e1-e4. PubMed ID: 30224331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
    Horsley A; Webb K; Bright-Thomas R; Govan J; Jones A
    Front Cell Infect Microbiol; 2011; 1():18. PubMed ID: 22919584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L
    New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.
    Murphy MP; Caraher E
    Pathog Dis; 2015 Nov; 73(8):ftv069. PubMed ID: 26371179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections.
    Zlosnik JE; Costa PS; Brant R; Mori PY; Hird TJ; Fraenkel MC; Wilcox PG; Davidson AG; Speert DP
    Am J Respir Crit Care Med; 2011 Jan; 183(1):67-72. PubMed ID: 20709823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid.
    Correa-Ruiz A; Girón R; Buendía B; Medina-Pascual MJ; Valenzuela C; López-Brea M; Sáez-Nieto JA
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):649-54. PubMed ID: 23528342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burkholderia cepacia complex bacteremia outbreaks among non-cystic fibrosis patients in the pediatric unit of a university hospital.
    Tüfekci S; Şafak B; Nalbantoğlu B; Samancı N; Kiraz N
    Turk J Pediatr; 2021; 63(2):218-222. PubMed ID: 33929111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcomes of Burkholderia cepacia complex bacteremia in patients without cystic fibrosis: a retrospective observational study.
    Lee YM; Park KH; Moon C; Kim DY; Lee MS; Kim T; Choo EJ; Chong YP; Kim SH; Kim YS; Woo JH; Chang MS
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2057-2064. PubMed ID: 32583228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
    Sabet M; Griffith DC
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712215
    [No Abstract]   [Full Text] [Related]  

  • 36. Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology.
    Vasiljevic ZV; Novovic K; Kojic M; Minic P; Sovtic A; Djukic S; Jovcic B
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1277-84. PubMed ID: 27177755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkholderia multivorans survival and trafficking within macrophages.
    Schmerk CL; Valvano MA
    J Med Microbiol; 2013 Feb; 62(Pt 2):173-184. PubMed ID: 23105020
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Gutiérrez Santana JC; Coria Jiménez VR
    Ann Med; 2024 Dec; 56(1):2307503. PubMed ID: 38261606
    [No Abstract]   [Full Text] [Related]  

  • 39. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.
    Garcia BA; Carden JL; Goodwin DL; Smith TA; Gaggar A; Leon K; Antony VB; Rowe SM; Solomon GM
    BMC Pulm Med; 2018 Feb; 18(1):35. PubMed ID: 29444656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taxonomy and pathogenesis of the Burkholderia cepacia complex.
    Mahenthiralingam E; Vandamme P
    Chron Respir Dis; 2005; 2(4):209-17. PubMed ID: 16541604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.